These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 30557871

  • 1. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F, Probst J, Brooks J, Hardin J, Qureshi Z.
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [Abstract] [Full Text] [Related]

  • 2. Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.
    Ajmal F, Probst JC, Brooks JM, Hardin JW, Qureshi Z, Jafar TH.
    Am J Kidney Dis; 2020 Feb; 75(2):177-186. PubMed ID: 31685294
    [Abstract] [Full Text] [Related]

  • 3. Early winners and losers in dialysis center pay-for-performance.
    Saunders MR, Lee H, Chin MH.
    BMC Health Serv Res; 2017 Dec 08; 17(1):816. PubMed ID: 29216894
    [Abstract] [Full Text] [Related]

  • 4. The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program.
    Breck A, Marr J, Turenne M, Esposito D.
    Med Care; 2022 Oct 01; 60(10):735-742. PubMed ID: 35880769
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2017 Nov 01; 82(210):50738-97. PubMed ID: 29091373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mortality Risk of Patients Treated in Dialysis Facilities with Payment Reductions under ESRD Quality Incentive Program.
    Griffin SM, Marr J, Kapke A, Jin Y, Pearson J, Esposito D, Young EW.
    Clin J Am Soc Nephrol; 2023 Mar 01; 18(3):356-362. PubMed ID: 36763812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes to the end-stage renal disease quality incentive program.
    Fishbane S, Miller I, Wagner JD, Masani NN.
    Kidney Int; 2012 Jun 01; 81(12):1167-71. PubMed ID: 22534963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.